Mitesco (MITI) Non-Current Deffered Revenue (2011 - 2013)
Mitesco (MITI) reported Non-Current Deffered Revenue of $2515.0 for Q4 2013, up 299.84% quarter-over-quarter from $629.0 in Q3 2013.
Mitesco (MITI) Non-Current Deffered Revenue (2011 - 2013) Analysis & Trends
Mitesco (MITI) has 3 years of Non-Current Deffered Revenue data on file, last reported at $2515.0 in Q4 2013.
- Non-Current Deffered Revenue for Q4 2013 came in at $2515.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2013 was $2515.0 (changed N/A YoY), and the FY2013 annual result was $2515.0, changed N/A from the prior year.
- Non-Current Deffered Revenue improved to $2515.0 in Q4 2013 per MITI's latest filing, from $629.0 in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $5914.0 in Q4 2011 and troughed at $629.0 in Q3 2013.
- A 3-year average of $2656.2 and a median of $2515.0 in 2013 frame the typical range for Non-Current Deffered Revenue.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 4.57 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 10.14 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 400,000.00 |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 5.16 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 63.07 Mn |
| 10 | Mitesco | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 2,515.00 |
| Sep 30, 2013 | 629.00 |
| Jun 30, 2012 | 845.00 |
| Mar 31, 2012 | 3,378.00 |
| Dec 31, 2011 | 5,914.00 |